Enhanced antibacterial activity of calcium silicate-based hybrid cements for bone repair

Mater Sci Eng C Mater Biol Appl. 2020 May:110:110727. doi: 10.1016/j.msec.2020.110727. Epub 2020 Feb 4.

Abstract

Calcium silicate cement has attracted much attention for bone defect repair and regeneration due to its osteogenic properties. Biomaterial-associated infections and washout have become a common clinical problem. In order to enhance the antibacterial and washout performance of calcium silicate cement to meet clinical needs, different types of chitosan, including chitosan polysaccharide (CTS), quaternary ammonium chitosan (QTS), and chitosan oligosaccharide (COS), as a liquid phase were added to the calcium silicate powder. The physicochemical properties, in vitro bioactivity, antibacterial efficacy, and osteogenic effects (MG63 cells) of the cement were evaluated. Antibacterial activity was conducted with Gram-negative Escherichia coli (E. coli) and a Gram-positive Staphylococcus aureus (S. aureus) bacteria. The amount of intracellular reactive oxygen species (ROS) produced in the bacteria cultured with the chitosan solution was also detected. The experimental results showed that the chitosan additive did not affect the crystalline phase of calcium silicate cement, but increased the setting time and strength of the cement in a concentration-dependent manner. Within the scope of this study, CTS and QTS solutions with a concentration of not <1 wt% improved the washout resistance of the control cement, while the COS solutions failed to strengthen the cement. When soaked in simulated body fluid (SBF) for 1 day, all cement samples formed apatite spherules. As the soaking time increased, the diametral tensile strength of all cements decreased and the porosity increased. The assays of MG63 cell function showed lower osteogenic activity of osteoblastic cells grown on the surfaces of the chitosan-incorporated cements in comparison with the control cement without chitosan. At the same 1% concentration, compared with QTS and COS cement, CTS cement had lower cell attachment, proliferation, differentiation, and mineralization. Conversely, the CTS cement resulted in the highest bacteriostasis ratio among the three hybrid cements against two bacteria. The ROS production followed the order of CTS > QTS > COS at the same 1% concentration. In conclusion, calcium silicate cement with 1% QTS may be a viable candidate for bone defect repair in view of anti-washout performance, setting time, antibacterial activity, and osteogenic activity shown in this study.

Keywords: Anti-washout; Antibacterial activity; Bone cement; Calcium silicate; Chitosan.

MeSH terms

  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Bone Cements* / chemistry
  • Bone Cements* / pharmacology
  • Calcium Compounds* / chemistry
  • Calcium Compounds* / pharmacology
  • Cell Line
  • Escherichia coli / growth & development*
  • Humans
  • Osteoblasts / cytology
  • Osteoblasts / metabolism*
  • Osteogenesis / drug effects*
  • Silicates* / chemistry
  • Silicates* / pharmacology
  • Staphylococcus aureus / growth & development*

Substances

  • Anti-Bacterial Agents
  • Bone Cements
  • Calcium Compounds
  • Silicates
  • calcium silicate